Intravesical recombinant BCG followed by perioperative chemo-immunotherapy for patients with muscle-invasive bladder cancer (MIBC): A multicenter, single arm phase 2 trial (SAKK 06/19). This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results